Share Doximity Facebook LinkedIn Twitter Print details The Model to Estimate Survival In Ambulatory HCC Patients (MESIAH) This calculator is intended for use by health care providers. The results should not be used alone to determine medical treatment. This tool is a statistical model and is not a substitute for an individual treatment plan developed by a health care provider with personal knowledge of a specific patient. Factors such as medical history and the health care provider’s experience, knowledge, and training must also be considered. Results should be discussed with patients when presenting prognoses or treatment recommendations. To estimate survival of ambulatory patients with hepatocellular carcinoma, please enter the following variables: What is the age(years)? IU/I What is the MELD score? IU/I What is serum albumin (g/dL)? What is the diameter of the largest tumor nodule (cm)? How many tumor nodules? Is there vascular invasion? Yes No Is there extrahepatic metastasis? Yes No What is serum AFP (ng/mL)? MESIAH score: Probability of Survival 1 Month 3 Months 6 Months 12 Months 24 Months 36 Months This online calculator is based on the following publication: Yang, JD. Model to estimate survival in ambulatory patients with hepatocellular carcinoma. Hepatology. 2012; 56: 614. http://www.ncbi.nlm.nih.gov/pubmed/22370914. Related ContentGALAD CalculatorSecond-line treatment options for hepatocellular carcinoma6 signs your patient is ready for liver transplant referralMaking up for lost time in GI cancers ITT-20434722 Medical Professionals The Model to Estimate Survival In Ambulatory HCC Patients (MESIAH)